Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Chromatics Color Sciences International. Inc; CCSI -- Ignore unavailable to you. Want to Upgrade?

To: Quad Sevens who wrote (2952)	6/11/1998 10:54:00 PM
From: Roger A. Babb	Read Replies (1) \| Respond to of 5736

Wade, I agree that the $300 million plus market estimate is misleading, but that is the CCSI estimate, not mine. They should be estimating the total potential revenue available to a supplier, not the amount billed to insurers which includes all sorts of hospital markups. And it is not realistic to give CCSI 100% market share. The existing suppliers will not just roll over, but will compete with improved products, lower prices, and more perks for doctors/hospitals.